首页 › 基金 › DMKC Advisory Services, LLC › ABT

DMKC Advisory Services, LLC 对 ABT 的持仓历史

ABBOTT LABORATORIES · 医疗保健

DMKC Advisory Services, LLC 在 Q3 2026 的 13F 申报中披露持有 ABT(ABBOTT LABORATORIES)34,891 股,市值约 US$3.4M,约占其申报组合的 0.85%,在其申报持仓中市值排名第 38 位。 DMKC Advisory Services, LLC 最近 8 个申报季度中有 8 个季度披露了 ABT 持仓,最早可追溯至 Q4 2024。

最新持仓 (Q3 2026)34.89K 股
申报持仓市值$3.45M
组合权重0.85%
首次申报Q4 2024
最近变动减持
更新于2026-11-05

最后更新: 2026-11-05 · 来源: SEC EDGAR Form 13F-HR

DMKC Advisory Services, LLC 对 ABT 的持仓演变

DMKC Advisory Services, LLC 于 Q4 2024 首次披露 ABT 持仓:15,365 股(约 US$1.7M)。 该持仓在 Q4 2025 达到峰值 33,228 股,市值约 US$4.2M。 在 8 次申报中,DMKC Advisory Services, LLC 5 次增持、2 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 34,891 股、市值约 US$3.4M,环比减持 -8,197 股。。 持仓曾出现大幅变动:Q2 2025 增持约 88% (随后一个季度股价下跌 1%)。

逐季持仓明细

季度股数金额变化
Q4 2024 15.37K $1.74M 新进
Q1 2025 15.57K $2.07M 增持
Q2 2025 29.29K $3.53M 增持
Q3 2025 28.75K $3.85M 减持
Q4 2025 33.23K $4.16M 增持
Q1 2026 35.27K $3.62M 增持
Q2 2026 43.09K $3.91M 增持
Q3 2026 34.89K $3.45M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 ABT 与 13F 数据

ABT(ABBOTT LABORATORIES)属于医疗保健行业。我们追踪的基金中还有 20 只申报持有 ABT,申报仓位最大的包括:先锋集团 (US$22.00B), 嘉信理财投资管理 (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 ABT 的基金

查看 ABT 的全部基金持有人 →

常见问题

How long has DMKC Advisory Services, LLC held ABT?

DMKC Advisory Services, LLC has disclosed ABT holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is DMKC Advisory Services, LLC's current position in ABT?

As of Q3 2026, DMKC Advisory Services, LLC holds 34.89K shares of ABT (ABBOTT LABORATORIES), valued at $3.45M, representing 0.85% of its reported portfolio and ranking #38.

Has DMKC Advisory Services, LLC been buying or selling ABT?

In the latest 13F filing (Q3 2026), DMKC Advisory Services, LLC reduced its position in ABT. The position peaked in Q4 2025 at 33.23K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include 先锋集团, 嘉信理财投资管理, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.